KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Incyte (INCY) Revenue (2016 - 2025)

Historic Revenue for Incyte (INCY) over the last 16 years, with Q4 2025 value amounting to $1.5 billion.

  • Incyte's Revenue rose 2783.89% to $1.5 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $5.1 billion, marking a year-over-year increase of 2122.09%. This contributed to the annual value of $5.1 billion for FY2025, which is 2122.09% up from last year.
  • Latest data reveals that Incyte reported Revenue of $1.5 billion as of Q4 2025, which was up 2783.89% from $1.4 billion recorded in Q3 2025.
  • In the past 5 years, Incyte's Revenue registered a high of $1.5 billion during Q4 2025, and its lowest value of $604.7 million during Q1 2021.
  • In the last 5 years, Incyte's Revenue had a median value of $922.9 million in 2022 and averaged $973.0 million.
  • In the last 5 years, Incyte's Revenue skyrocketed by 3099.11% in 2021 and then skyrocketed by 126.89% in 2022.
  • Incyte's Revenue (Quarter) stood at $862.9 million in 2021, then grew by 7.4% to $926.7 million in 2022, then rose by 9.35% to $1.0 billion in 2023, then increased by 16.32% to $1.2 billion in 2024, then increased by 27.84% to $1.5 billion in 2025.
  • Its last three reported values are $1.5 billion in Q4 2025, $1.4 billion for Q3 2025, and $1.2 billion during Q2 2025.